Want to join the conversation?
$K raised its 2016 EPS on currency-neutral comparable basis guidance to $4.11-4.18 from previous forecast of $4.00-4.07. The increase is driven by higher currency-neutral comparable operating profit, which is now expected to rise by 15-17%, up from prior estimate of 11-13%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?